S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
S&P 500   4,701.21
DOW   35,754.75
QQQ   399.61
NYSE:CBT

Cabot Stock Forecast, Price & News

$56.40
+0.34 (+0.61%)
(As of 12/8/2021 12:00 AM ET)
Add
Compare
Today's Range
$55.89
$56.94
50-Day Range
$50.12
$59.68
52-Week Range
$40.91
$65.25
Volume
229,389 shs
Average Volume
336,797 shs
Market Capitalization
$3.20 billion
P/E Ratio
13.00
Dividend Yield
2.64%
Beta
1.64
30 days | 90 days | 365 days | Advanced Chart
Receive CBT News and Ratings via Email

Sign-up to receive the latest news and ratings for Cabot and its competitors with MarketBeat's FREE daily newsletter.


Cabot logo

About Cabot

Cabot Corp. is a global specialty chemicals and performance materials company. Its products are rubber and specialty grade carbon blacks, specialty compounds, fumed metal oxides, activated carbons, inkjet colorants, and aerogel. The company operates through the following segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The Reinforcement Materials segment involves the rubber blacks and elastomer composites product lines. The Performance Chemicals segment combines the specialty carbons and compounds and inkjet colorants product lines into the specialty carbons and formulations business. The Purification Solutions segment refers to the activated carbon business and the specialty fluids segment. Cabot was founded by Godfrey Lowell Cabot in 1882 and is headquartered in Boston, MA.

Headlines

Cabot (NYSE:CBT) Price Target Cut to $60.00
December 7, 2021 |  americanbankingnews.com
Cabot (NYSE:CBT) Price Target Raised to $72.00 at Barclays
December 3, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous chemical products
Sub-Industry
Commodity Chemicals
CUSIP
12705510
Employees
4,500
Year Founded
N/A

Sales & Book Value

Annual Sales
$3.41 billion
Cash Flow
$8.33 per share
Book Value
$19.19 per share

Profitability

Net Income
$250 million
Pretax Margin
11.91%

Debt

Price-To-Earnings

Miscellaneous

Free Float
55,792,000
Market Cap
$3.20 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/07/2021
Ex-Dividend
11/24/2021
Today
12/09/2021
Dividend Payable
12/10/2021
Next Earnings (Estimated)
2/07/2022
Fiscal Year End
9/30/2022

MarketRank

Overall MarketRank

2.82 out of 5 stars

Basic Materials Sector

30th out of 223 stocks

Miscellaneous Chemical Products Industry

2nd out of 10 stocks

Analyst Opinion: 3.3Community Rank: 4.1Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -












Cabot (NYSE:CBT) Frequently Asked Questions

Is Cabot a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last twelve months. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cabot stock.
View analyst ratings for Cabot
or view top-rated stocks.

How has Cabot's stock price been impacted by Coronavirus (COVID-19)?

Cabot's stock was trading at $29.91 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CBT stock has increased by 88.6% and is now trading at $56.40.
View which stocks have been most impacted by COVID-19
.

When is Cabot's next earnings date?

Cabot is scheduled to release its next quarterly earnings announcement on Monday, February 7th 2022.
View our earnings forecast for Cabot
.

How were Cabot's earnings last quarter?

Cabot Co. (NYSE:CBT) posted its quarterly earnings data on Sunday, November, 7th. The specialty chemicals company reported $1.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.03 by $0.08. The specialty chemicals company earned $904 million during the quarter, compared to the consensus estimate of $914.88 million. Cabot had a trailing twelve-month return on equity of 28.15% and a net margin of 7.33%. The firm's revenue was up 37.2% compared to the same quarter last year. During the same period last year, the firm earned $0.68 earnings per share.
View Cabot's earnings history
.

How often does Cabot pay dividends? What is the dividend yield for Cabot?

Cabot declared a quarterly dividend on Friday, November 12th. Stockholders of record on Friday, November 26th will be paid a dividend of $0.37 per share on Friday, December 10th. This represents a $1.48 annualized dividend and a dividend yield of 2.62%. The ex-dividend date of this dividend is Wednesday, November 24th. This is a boost from Cabot's previous quarterly dividend of $0.35.
View Cabot's dividend history
.

Is Cabot a good dividend stock?

Cabot pays an annual dividend of $1.48 per share and currently has a dividend yield of 2.64%. Cabot does not yet have a strong track record of dividend growth. The dividend payout ratio of Cabot is 34.10%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cabot will have a dividend payout ratio of 24.87% next year. This indicates that Cabot will be able to sustain or increase its dividend.
View Cabot's dividend history.

What guidance has Cabot issued on next quarter's earnings?

Cabot issued an update on its FY 2022 earnings guidance on Monday, December, 6th. The company provided earnings per share (EPS) guidance of $5.200-$5.600 for the period, compared to the Thomson Reuters consensus estimate of $5.520. The company issued revenue guidance of -.

What price target have analysts set for CBT?

7 Wall Street analysts have issued 12-month price objectives for Cabot's shares. Their forecasts range from $60.00 to $143.00. On average, they expect Cabot's stock price to reach $81.57 in the next twelve months. This suggests a possible upside of 44.6% from the stock's current price.
View analysts' price targets for Cabot
or view top-rated stocks among Wall Street analysts.

Who are Cabot's key executives?

Cabot's management team includes the following people:
  • Sean D. Keohane, President, Chief Executive Officer & Director
  • Erica J. McLaughlin, Chief Financial Officer & Senior Vice President
  • Patricia Hubbard, Chief Technology Officer & Senior Vice President
  • Hobart C. Kalkstein, SVP & President-Reinforcement Materials segment
  • Karen A. Kalita, Senior Vice President & General Counsel

What is Sean Keohane's approval rating as Cabot's CEO?

40 employees have rated Cabot CEO Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among Cabot's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cabot own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

What is Cabot's stock symbol?

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Who are Cabot's major shareholders?

Cabot's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.67%), Fuller & Thaler Asset Management Inc. (6.05%), LSV Asset Management (4.46%), Wellington Management Group LLP (4.41%), Victory Capital Management Inc. (3.91%) and Dimensional Fund Advisors LP (3.02%). Company insiders that own Cabot stock include Hobart Kalkstein and Karen A Kalita.
View institutional ownership trends for Cabot
.

Which major investors are selling Cabot stock?

CBT stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Citigroup Inc., BlackRock Inc., Millennium Management LLC, Cubist Systematic Strategies LLC, Renaissance Technologies LLC, LSV Asset Management, and Arrowstreet Capital Limited Partnership.
View insider buying and selling activity for Cabot
or view top insider-selling stocks.

Which major investors are buying Cabot stock?

CBT stock was bought by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Victory Capital Management Inc., Peregrine Capital Management LLC, Grantham Mayo Van Otterloo & Co. LLC, Wellington Management Group LLP, Tudor Investment Corp Et Al, Hillsdale Investment Management Inc., and Deutsche Bank AG.
View insider buying and selling activity for Cabot
or or view top insider-buying stocks.

How do I buy shares of Cabot?

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cabot's stock price today?

One share of CBT stock can currently be purchased for approximately $56.40.

How much money does Cabot make?

Cabot has a market capitalization of $3.20 billion and generates $3.41 billion in revenue each year. The specialty chemicals company earns $250 million in net income (profit) each year or $4.34 on an earnings per share basis.

How many employees does Cabot have?

Cabot employs 4,500 workers across the globe.

What is Cabot's official website?

The official website for Cabot is www.cabot-corp.com.

Where are Cabot's headquarters?

How can I contact Cabot?

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at [email protected], or via fax at 617-342-6103.


This page was last updated on 12/9/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.